White Paper
India: Emerging Hub for Obesity Clinical Trials
Oct 29, 2025
Discover why India is rapidly becoming a global hub for obesity clinical trials. This white paper highlights India's unique strengths, including a large, diverse treatment-naïve patient pool, streamlined regulatory reforms (NDCT rules, DCGI), cost-effective trial operations, and advanced digital health and AI-driven solutions. Learn how pharmaceutical companies can leverage India's robust clinical infrastructure, strong CRO and hospital partnerships, and innovative recruitment strategies to accelerate obesity research and deliver scalable, high-quality outcomes.
Contact Us